Andrew Huberman· PhD
and that’s why you’re unlikely to see heavy regulation provided things are coming from compounding pharmacies
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and that’s why you’re unlikely to see heavy regulation provided things are coming from compounding pharmacies
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Typically the response is “compounded”. (Not gray or black market).
Manufacturing, Compounding Pharmacies, Gray Market, Black Market
GLPs & Compounding Pharmacy; Peptides & Gray Market
Manufacturing, Compounding Pharmacies, Gray Market, Black Market
GLPs & Compounding Pharmacy; Peptides & Gray Market